Robuta

https://www.biospace.com/press-releases/optinose-announces-preliminary-unaudited-fourth-quarter-2024-xhance-net-revenue-of-22-4-million
fourth quarternet revenueannouncespreliminaryxhance
https://www.xhance.com/
XHANCE is a prescription medicine used to treat chronic rhinosinusitis with or without nasal polyps in adults.
chronic sinusitistreatmentxhance